Bupropion Hydrochloride 150 mg
1 INDICATIONS AND USAGE Bupropion hydrochloride extended-release tablets (SR) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies ( 14 )] . The efficacy of bupropion hydrochloride extended-release tablets (SR) in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see Clinical Studies ( 14 )] . Bupropion hydrochloride extended-release tablets, (SR) are an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD). ( 1 )
ScieGen Pharmaceuticals, Inc.
ROUND PURPLE SG 175
SG 175 ROUND PURPLE
Related Pills
Bupropion Hydrochloride 150 mg
sciegen pharmaceuticals, inc.
bupropion 200 mg
sciegen pharmaceuticals, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
BUPROPION HYDROCHLORIDE extended-release tablets, USP (SR), 100 mg of
BUPROPION HYDROCHLORIDE, are blue, blackberry flavored, round, biconvex, film coated tablets, debossed with ‘SG, 174’ on one side and plain on other side in Bottles of 30 (NDC 50228-174-30) Tablets Bottles of 60 (NDC 50228-174-60) Tablets Bottles of 100 (NDC 50228-174-01) Tablets Bottles of 500 (NDC 50228-174-05) Tablets Bottles of 1000 (NDC 50228-174-10) Tablets
BUPROPION HYDROCHLORIDE extended-release tablets, USP (SR), 150 mg of
BUPROPION HYDROCHLORIDE, are purple, blackberry flavored, round, biconvex, film coated tablets, debossed with ‘SG, 175’ on one side and plain on other side in Bottles of 30 (NDC 50228-175-30) Tablets Bottles of 60 (NDC 50228-175-60) Tablets Bottles of 100 (NDC 50228-175-01) Tablets Bottles of 500 (NDC 50228-175-05) Tablets Bottles of 1,000 (NDC 50228-175-10) Tablets
BUPROPION HYDROCHLORIDE extended-release tablets, USP (SR), 200 mg of
BUPROPION HYDROCHLORIDE, are pink, blackberry flavored, round, biconvex, film coated tablets, debossed with ‘SG, 176’ on one side and plain on other side in Bottles of 30 (NDC 50228-176-30) Tablets Bottles of 60 (NDC 50228-176-60) Tablets Bottles of 100 (NDC 50228-176-01) Tablets Bottles of 1,000 (NDC 50228-176-10) Tablets Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure (as required). Protect from light and moisture.
More pills like ROUND SG 175